Compounds > phenyl-n-tert-butylnitrone

phenyl-n-tert-butylnitrone and Alloxan Diabetes

phenyl-n-tert-butylnitrone has been researched along with Alloxan Diabetes in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, ZY; Li, XL; Liu, X; Ma, Q; Wang, C; Zhao, X; Zhou, DS; Zhou, WH1
Floyd, RA; Jacob, JM; Kotake, Y; Tabatabaie, T; Wallis, G1
Bray, TM; Chen, G; Ho, E2

Other Studies

4 other study(ies) available for phenyl-n-tert-butylnitrone and Alloxan Diabetes

ArticleYear
Antinociceptive effects of fisetin against diabetic neuropathic pain in mice: Engagement of antioxidant mechanisms and spinal GABAA receptors.
    Pharmacological research, 2015, Volume: 102

    Topics: Analgesics; Animals; Antioxidants; Bicuculline; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Flavonoids; Flavonols; Ganglia, Spinal; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Neuralgia; Oxidative Stress; Reactive Oxygen Species; Receptors, GABA-A; Spinal Cord; Streptozocin

2015
Spin trapping agent phenyl N-tert-butylnitrone protects against the onset of drug-induced insulin-dependent diabetes mellitus.
    FEBS letters, 1997, Apr-28, Volume: 407, Issue:2

    Topics: Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electron Spin Resonance Spectroscopy; Glycated Hemoglobin; Hyperglycemia; Islets of Langerhans; Male; Mice; Mice, Inbred BALB C; Nitrogen Oxides; Spin Trapping; Streptozocin; Weight Loss

1997
Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1999, Volume: 13, Issue:13

    Topics: Acetylcysteine; Administration, Oral; Alloxan; Animals; Blood Glucose; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Free Radicals; Glutathione; Male; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Pancreas

1999
Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes.
    Free radical biology & medicine, 2000, Feb-15, Volume: 28, Issue:4

    Topics: Alloxan; Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Free Radicals; Hyperglycemia; Islets of Langerhans; Male; Mice; NF-kappa B; Nitrogen Oxides; Reactive Oxygen Species; Spin Labels; Streptozocin

2000